Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Mobix Labs, Inc. notified the SEC it cannot timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 under Rule 12b-25 because of accounting department turnover and the need for additional time to finalize its financial statements and disclosure controls. The company provided preliminary results: loss from operations of approximately $6.1 million, net revenues of approximately $970 thousand, and a net loss of approximately $5.9 million for the quarter ended March 31, 2026. The company stated its financial statements will continue to reflect substantial doubt about its ability to continue as a going concern for the next twelve months and expects to file the Form 10-Q within the extension period.
Mobix Labs, Inc. is registering the resale of up to 2,500,000 shares of Class A Common Stock, representing shares issuable upon conversion of a $3,000,000 senior secured convertible promissory note held by Leviston Resources, LLC. The company will receive no proceeds from these resales and the registration covers shares that would equal approximately 23.94% of outstanding Class A Common Stock as of April 16, 2026. The prospectus warns that the resale or market perception of these sales could materially depress the trading price of the Class A Common Stock.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs, Inc. director Michael J. Long reported equity awards in the company’s Class A common stock. He received 14,805 shares on February 25, 2026 and an additional 5,000 shares on March 30, 2026, both recorded as grants or awards at a price of $0.00 per share.
After these transactions, Long directly owned 124,932 shares of Class A common stock. A footnote explains that an earlier grant of Restricted Stock Units was made on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership was adjusted for rounding following a 1-for-10 reverse stock split effective April 6, 2026.
Mobix Labs director Kurt Busch reported new equity awards in Mobix Labs, Inc. Class A Common Stock. He received 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026 as grant or award acquisitions at no stated purchase price.
After these awards, Busch directly owns 60,961 Class A shares. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030. Reported holdings reflect a 1-for-10 reverse stock split on April 6, 2026.
MOBIX Labs director and 10% owner James J. Peterson reported stock awards and updated holdings in the company’s shares. He received Class A Common Stock awards of 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026, both at $0.00 per share as grants.
Following the latest award, he directly holds 325,462 shares of Class A Common Stock. Footnotes state these Restricted Stock Units were granted on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership figures were adjusted for a 1-for-10 reverse stock split effective April 6, 2026. He also holds Class B Common Stock convertible into 144,927 Class A shares at the holder’s option, plus fully vested options over 13,341 Class A shares at an exercise price of $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Frederick C. Goerner reported stock-based compensation awards rather than open‑market trades. He received grants of 14,805 and 5,000 shares of Class A Common Stock at a price of $0.00 per share, described as restricted stock units that were granted on February 25, 2026 and vested on April 1, 2026.
After these awards, he directly owns 172,057 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at an exercise price of $0.00, plus fully vested options covering 13,341 shares at $68.40 per share and 2,000 shares at $41.80 per share.
ALDRICH DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director David J. Aldrich reported equity awards in MOBX stock. He received grants of 14,805 shares of Class A Common Stock on February 25, 2026 and 5,000 shares on March 30, 2026, both at a stated price of $0.00 per share, reflecting compensation rather than open‑market purchases. Following these awards, he directly holds 52,693 Class A shares. Footnotes state the February 25, 2026 award consisted of Restricted Stock Units that vested on April 1, 2026, and that his beneficial ownership has been adjusted for a 1‑for‑10 reverse stock split effective April 6, 2026. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Bill Carpou reported new equity awards in the form of Class A Common Stock. On February 25, 2026 and March 30, 2026, he received stock awards of 14,805 and 5,000 shares, respectively, at $0.00 per share as grant/award acquisitions. Footnotes state these awards relate to Restricted Stock Units granted on February 25, 2026 that vested on April 1, 2026.
Following these awards, Carpou directly owns 53,622 shares of Class A Common Stock. He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options for 2,000 shares at $41.80 per share expiring on August 10, 2030. A footnote notes his beneficial ownership share count was adjusted for a 1-for-10 reverse stock split effected on April 6, 2026.
MOBIX Labs, Inc. director and CEO Philip Sansone reported an open-market sale of 9,541 shares of Class A Common Stock. The shares were sold at a weighted average price of $2.3544 per share to cover tax liabilities from restricted stock units that vested on April 30, 2026, under an irrevocable sell-to-cover election and not as discretionary trades.
After these transactions, Sansone directly holds 175,431 shares of Class A Common Stock. The company effected a 1-to-10 reverse stock split on April 6, 2026, which reduced his direct holdings.